thalidomide has been researched along with Duncan Disease in 9 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic enterocolitis is rare in infancy and accounts for less than 0." | 1.33 | Long-term outcome of intractable ulcerating enterocolitis of infancy. ( Lindley, KJ; Milla, PJ; Ramsay, AD; Shah, N; Thapar, N, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, YY | 1 |
| Au-Yeung, R | 1 |
| Lau, HP | 1 |
| Kwong, YL | 1 |
| Xu, M | 1 |
| Hou, Y | 1 |
| Sheng, L | 1 |
| Peng, J | 1 |
| Quintanilla-Martinez, L | 1 |
| Ridaura, C | 1 |
| Nagl, F | 1 |
| Sáez-de-Ocariz, M | 1 |
| Durán-McKinster, C | 1 |
| Ruiz-Maldonado, R | 1 |
| Alderete, G | 1 |
| Grube, P | 1 |
| Lome-Maldonado, C | 1 |
| Bonzheim, I | 1 |
| Fend, F | 1 |
| Francis, SM | 1 |
| Taylor, CA | 1 |
| Tang, T | 1 |
| Liu, Z | 1 |
| Zheng, Q | 1 |
| Dondero, R | 1 |
| Thompson, JE | 1 |
| Cozzani, E | 1 |
| Gasparini, G | 1 |
| Parodi, A | 1 |
| Läubli, H | 1 |
| Tzankov, A | 1 |
| Juskevicius, D | 1 |
| Degen, L | 1 |
| Rochlitz, C | 1 |
| Stenner-Liewen, F | 1 |
| Ninan, MJ | 1 |
| Datta, YH | 1 |
| Thapar, N | 1 |
| Shah, N | 1 |
| Ramsay, AD | 1 |
| Lindley, KJ | 1 |
| Milla, PJ | 1 |
| Portell, C | 1 |
| Nand, S | 1 |
3 reviews available for thalidomide and Duncan Disease
| Article | Year |
|---|---|
Therapeutic effects of thalidomide in hematologic disorders: a review.
Topics: Angiogenesis Inhibitors; Clinical Trials as Topic; Graft vs Host Disease; Hematologic Neoplasms; Hum | 2013 |
Pyoderma gangrenosum: a systematic review.
Topics: Anti-Inflammatory Agents; Arthritis; Dermatologic Agents; Diagnosis, Differential; Disease Progressi | 2014 |
Post-transplant lymphoproliferative disorder presenting as multiple myeloma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
6 other studies available for thalidomide and Duncan Disease
| Article | Year |
|---|---|
Complete response of age-related Epstein-Barr virus-associated polymorphic nodal lymphoproliferative disease of plasmacytic type to low-dose lenalidomide.
Topics: Aged, 80 and over; Aging; Antigens, CD; Epstein-Barr Virus Infections; Humans; Immunocompromised Hos | 2018 |
Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
Topics: Adolescent; Child; Child, Preschool; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Herpe | 2013 |
SNS01-T modulation of eIF5A inhibits B-cell cancer progression and synergizes with bortezomib and lenalidomide.
Topics: Animals; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship | 2014 |
Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder.
Topics: Adult; B-Lymphocytes; Biopsy; Epstein-Barr Virus Infections; Female; Genomics; Hematopoietic Stem Ce | 2016 |
Long-term outcome of intractable ulcerating enterocolitis of infancy.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Colectomy; Colitis, Ulcer | 2005 |
Single agent lenalidomide induces a response in refractory T-cell posttransplantation lymphoproliferative disorder.
Topics: Drug Resistance; Fatal Outcome; Female; Humans; Immunologic Factors; Kidney Transplantation; Lenalid | 2008 |